Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

T.E. Tshikalange

T.E. Tshikalange

University of Pretoria, South Africa

Title: Bioactivity of selected medicinal plants used for the treatment of sexually transmitted diseases

Biography

Biography: T.E. Tshikalange

Abstract

Sexually transmitted diseases have a major impact on sexual and reproductive health worldwide. Each year, the World Health Organization estimates 448 million new cases of curable STD’s are diagnosed. Ethanol extracts of twelve South African medicinal plants used in the treatment of STD’s and 3 flavonoids were investigated for their antimicrobial activity against Candida albicans, Gardnerella vaginalis, Neisseria gonorrhoeae and Oligella ureolytica. The anti-inflammatory activities of the extracts and compounds were determined by measuring the inhibitory effect of the extracts and compounds on the pro-inflammatory enzyme lipoxygenase. The extracts and compounds were also investigated for their anti-HIV activities against recombinant HIV-1 enzyme using non-radioactive HIV-RT colorimetric assay. Acacia karroo and Rhoicissus tridentata extracts showed good antimicrobial activity with MIC values ranging between 0.4 and 3.1 mg/ml. Extracts of Jasminum fluminense, Solanum tomentosum and flavonoids 2 and 3 had good anti-inflammatory activity with IC50 less than the positive control, quercetin (IC50 = 48.86 ug/ml). A. karroo and flavonoid 3 exhibited moderate HIV-1 RT inhibition activity of 66.8 and 63.7 % respectively. R. tridentata and Terminalia sericea had the best RT inhibition activity (75.7 and 100 %) compared to that of the positive control doxorubicin (96.5%) at 100 ug/ml concentration. The emergence of drug resistance in STD related microorganisms and potential side effects demand the discovery of newer drugs. The exploration of newer anti-microbial substances from natural sources may serve as promising alternatives. The observed activities may lead to new multi-target drugs against sexually transmitted diseases.